⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29749227 | 0.71 | — | — | |
| SCHEMBL991546 | 0.70 | — | — | |
| SCHEMBL27499006 | 0.66 | — | — | |
| SCHEMBL29044000 | 0.64 | — | — | |
| SCHEMBL8308240 | 0.64 | — | — | |
| SCHEMBL28073190 | 0.62 | — | — | |
| SCHEMBL27535678 | 0.60 | NFKB1 (0.32) | — | |
| SCHEMBL25414445 | 0.57 | CASP6 (0.30) | — | |
| SCHEMBL7048152 | 0.57 | — | — | |
| SCHEMBL11040064 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8551961-B2 | Localized delivery of cardiac inotropic agents | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-10-08 | — | — | US | disclosed |
| EP-2217251-A1 | METHODS OF AUGMENTING OR REPAIRING SOFT TISSUE | Genzyme Corporation (US) | 2010-08-18 | — | — | EP | disclosed |
| WO-2009059121-A1 | METHODS OF AUGMENTING OR REPAIRING SOFT TISSUE | GENZYME CORPORATION (US) | 2009-05-07 | — | — | WO | disclosed |
| US-20090117188-A1 | Methods of Augmenting or Repairing Soft Tissue | GENZYME CORPORATION | 2009-05-07 | — | — | US | disclosed |
| EP-1888049-A2 | LOCALIZED DELIVERY OF CARDIAC INOTROPIC AGENTS | THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2008-02-20 | — | — | EP | disclosed |
| US-20070021358-A1 | Localized delivery of cardiac inotropic agents | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2007-01-25 | — | — | US | disclosed |
| WO-2006127907-A2 | LOCALIZED DELIVERY OF CARDIAC INOTROPIC AGENTS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2006-11-30 | — | — | WO | disclosed |
| US-20060093673-A1 | Controlled release of anti-arrhythmic agents | GENZYME CORPORATION | 2006-05-04 | — | — | US | disclosed |
| US-7022343-B2 | Controlled release of anti-arrhythmic agents | GENZYME CORPORATION (US) | 2006-04-04 | — | — | US | disclosed |
| EP-1347756-B1 | CONTROLLED RELEASE OF ANTI-ARRHYTHMIC AGENTS FROM A BIODEGRADABLE HYDROGEL FOR LOCAL APPLICATION TO THE HEART | GENZYME CORP (US) | 2006-03-08 | — | — | EP | disclosed |
| EP-1586349-A1 | Controlled release of anti-arrhythmic agents | Genzyme Corporation (US) | 2005-10-19 | — | — | EP | disclosed |
| EP-1551368-A1 | CONTROLLED RELEASE OF ANTI-ARRHYTHMIC AGENTS | Genzyme Corporation (US) | 2005-07-13 | — | — | EP | disclosed |
| WO-2004002449-A1 | CONTROLLED RELEASE OF ANTI-ARRHYTHMIC AGENTS | GENZYME CORPORATION (US) | 2004-01-08 | — | — | WO | disclosed |
| EP-1347756-A2 | CONTROLLED RELEASE OF ANTI-ARRHYTHMIC AGENTS FROM A BIODEGRADABLE POLYETHYLENE OXIDE HYDROGEL FOR LOCAL APPLICATION TO THE HEART | GENZYME CORPORATION (US) | 2003-10-01 | — | — | EP | disclosed |
| US-20020150622-A1 | Controlled release of anti-arrhythmic agents | GENZYME CORPORATION | 2002-10-17 | — | — | US | disclosed |
| WO-2002051383-A2 | CONTROLLED RELEASE OF ANTI-ARRHYTHMIC AGENTS FROM A BIODEGRADABLE POLYETHYLENE OXIDE HYDROGEL FOR LOCAL APPLICATION TO THE HEART | GENZYME CORPORATION (US) | 2002-07-04 | — | — | WO | disclosed |